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Abstract
Membrane fusion is essential for eukaryotic life, requiring SNARE
proteins to zipper up in an a-helical bundle to pull two
membranes together. Here, we show that vesicle fusion can be
suppressed by phosphorylation of core conserved residues inside
the SNARE domain. We took a proteomics approach using a PKCB
knockout mast cell model and found that the key mast cell secre-
tory protein VAMP8 becomes phosphorylated by PKC at multiple
residues in the SNARE domain. Our data suggest that VAMP8
phosphorylation reduces vesicle fusion in vitro and suppresses
secretion in living cells, allowing vesicles to dock but preventing
fusion with the plasma membrane. Markedly, we show that the
phosphorylation motif is absent in all eukaryotic neuronal VAMPs,
but present in all other VAMPs. Thus, phosphorylation of SNARE
domains is a general mechanism to restrict how much cells
secrete, opening the door for new therapeutic strategies for
suppression of secretion.
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Introduction
Animal cells maintain tissue function by secreting regulatory factors
to signal their activity and nutrient status, pathogen infections, or
injury. These regulated vesicle fusion events are typically much
slower than the Ca2+-triggered release of synaptic vesicles (Wickner
& Schekman, 2008; Su¨dhof & Rothman, 2009; Jahn & Fasshauer,
2012; Wollman & Meyer, 2012; Su¨dhof, 2013) and require in
addition to SNARE proteins signaling regulators such as protein
kinase C (PKC) (Oancea & Meyer, 1998; Nechushtan et al, 2000;
Newton, 2010). Despite decades of investigation, the role of PKC in
vesicle secretion remains incompletely resolved (Nishizuka, 1986;
Leitges et al, 1996; Kalesnikoff & Galli, 2008; Lorentz et al, 2012),
but may involve incoherent feed-forward regulation (Mangan &
Alon, 2003) as PKC is known to both activate (Nechushtan et al,
2000; Newton, 2010) and suppress (McHugh et al, 2000; Leitges
et al, 2002; Bousquet et al, 2010) numerous cell responses. Incoher-
ent feed-forward circuits are formed when a single signaling protein
induces two opposing pathways that activate and inhibit the same
cell response (Mangan & Alon, 2003). This ubiquitous circuit motif
allows cells to shape the time course of functional outputs (Kim
et al, 2008; Ma et al, 2009).
SNAREs are key components of the protein complexes that drive
membrane fusion. While many SNARE-associated proteins are
known to influence vesicle fusion (Jahn & Fasshauer, 2012), less is
known about posttranslational regulation of SNARE proteins in
general and in particular about phosphorylation of SNARE domains
which form a-helices in the SNARE complex (Sutton et al, 1998).
One phosphorylation site in the SNARE domain of SNAP25, S187,
has been widely studied (Shimazaki et al, 1996). Phosphorylation of
S187 increases secretion (Shu et al, 2008) and the crystal structure
of the SNARE complex reveals that S187 forms part of the outside
surface area of the a-helical bundle (Fasshauer et al, 1998; Sutton
et al, 1998; Nagy et al, 2002). Additional SNARE domain phospho-
rylation sites have been reported: SNAP23 (S23, T24, and S160)
(Polga´r et al, 2003) and VAMP2 (T35 and S61) (Hirling & Scheller,
1996; Li et al, 2009), but their involvement in secretion has not
been well defined.
Here, we discovered that phosphorylation by PKCB of residues
within the SNARE domain of VAMP8 suppresses mast cell secre-
tion. A phosphomimetic VAMP8 mutant reduces the kinetics of
SNARE-mediated vesicle fusion in vitro. The phosphorylation sites
identified in VAMP8 forms part of the interaction surface facing
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the inside of the helical bundle of the SNARE complex, suggest-
ing that this particular phosphorylation interferes with SNARE
complex formation. Furthermore, we demonstrate that PKCB is
both promoting and inhibiting secretion, thus forming an inco-
herent feed-forward loop, where phosphorylation of VAMP8
constitutes the negative arm that limits secretion by preventing
vesicle fusion.
Results
Systematic identification of secretion-related phosphorylation
targets of PKCB
We employed a proteomics approach to identify PKCB substrates
that may control the induction and inhibition of secretion as part of
an incoherent feed-forward regulation. We used tumor mast cells
(rat basophilic leukemia cells, RBL-2H3; Kalesnikoff & Galli, 2008;
Wollman & Meyer, 2012) which secrete only part (~30%) of their
stored inflammatory agents in response to maximal antigen stimula-
tion (Fig 1A), consistent with the existence of inhibitory pathways
that prevent the release of the remaining vesicles. Since previous
studies proposed that PKCB is the main PKC isoform regulating mast
cell secretion (Nechushtan et al, 2000), we confirmed that inhibition
of PKCB with ruboxistaurin (Ishii et al, 1996; Tsai et al, 2014)
further reduces the amount of released vesicles in a dose-dependent
manner following stimulation with antigen (Fig 1A) or simultaneous
addition of the PKC activators phorbol ester and Ca2+ ionophore
(Fig EV1A).
We generated a PKCB knockout RBL cell line using genome edit-
ing with TALENs by targeting the first exon of PKCB and deleting
the three PKCB copies present in RBL cells (Fig EV1B). The double-
strand cuts resulted in repair by non-homologous end joining lead-
ing to deletions in all three alleles as demonstrated by sequencing of
genomic DNA (Fig EV1B). Western blot analysis confirmed that
PKCB protein expression was abolished (Fig 1B). These knockout
cells showed a ~50% reduction in secretion compared to the wild-
type cells, a reduction that could be rescued by stable overexpres-
sion of either one of the two PKCB splice variants, PKCB1 or PKCB2
(Fig 1C). The remaining secretory activity in the PKCB knockout
cells could be further reduced by knockdown of the PKCB homolog
PKCA (Fig EV1C), suggesting that other PKC genes may contribute
to the remaining secretion response. Additional control experiments
showed that antigen-triggered Ca2+ increases were the same in
wild-type and PKCB knockout RBL cells (Fig EV1D and E). We
employed phosphoproteomics to gain a comprehensive under-
standing of which of the many known inducers and suppressors of
secretion might be regulated by PKCB. Specifically, we compared
phosphopeptides derived from stimulated wild-type cells to
phosphopeptides derived from either PKCB knockout cells or
wild-type cells treated with a PKCB blocker (10 lM ruboxistaurin)
(Fig EV2A). The list of 17,700 phosphopeptides that could be repro-
ducibly identified between biological replicates (Figs 1D and EV2A
and B) was pruned to 179 by selecting only peptides containing
evolutionarily conserved phosphorylation sites (Zhao et al, 2012),
that in addition were known or proposed secretion regulators
(Materials and Methods) (Fig 1E), and that were also at least
twofold more abundant in control cells compared to PKCB
knockout cells or cells treated with PKCB inhibitor (Fig 1F and
Appendix Table S1).
Markedly, this pruned list contained 2 phosphopeptides from a
100 amino acid long SNARE protein (Figs 1F and EV2C), vesicular-
associated membrane protein 8 (VAMP8), that is known to be criti-
cal for the fusion of vesicles with the plasma membrane during mast
cell secretion (Lippert et al, 2007; Puri & Roche, 2008; Tiwari et al,
2008) but was not previously known to be regulated by phosphory-
lation. Using antibody staining, we confirmed that VAMP8 localizes
to secretory granules before stimulation and translocates to the
plasma membrane after antigen stimulation (Fig 1G). This is consis-
tent with the role of VAMP8 as a secretory vesicle protein, v-SNARE,
that forms together with the t-SNARE (syntaxins and SNAP23)
complexes that mediate the fusion of secretory vesicles with the
plasma membrane (Sakiyama et al, 2009; Jahn & Fasshauer, 2012;
Lorentz et al, 2012; Brochetta et al, 2014).
Non-synaptic VAMPs have evolutionarily conserved
phosphorylation sites located deep inside the SNARE complex
The soluble part of the SNARE complex consists of four a-helices
(SNARE domains) (Fasshauer et al, 1998; Sutton et al, 1998;
Su¨dhof & Rothman, 2009). Surprisingly, the phosphorylation sites
in VAMP8 that we identified face the 3 other a-helices of the
SNARE complex (Fig 2A) (Fasshauer et al, 1998; Sutton et al,
1998; Diao et al, 2015) as part of the 16 conserved SNARE layers
(Fasshauer et al, 1998) that are buried inside the SNARE complex
(T47 at layer +3, S54 at layer +5, and T53 close to layer +5)
(Figs 2B–D and EV2C). An additional site was listed as a putative
phosphorylation site in the PhosphoSitePlus (Hornbeck et al, 2015)
database (S61 at layer +7).
Markedly, these serine and threonine phosphorylation sites
inside the SNARE complex are highly conserved in all non-
synaptic VAMP subfamilies going back to plants (Fig 2E). In
contrast, the well-studied VAMP2 (synaptobrevin) (Jahn &
Fasshauer, 2012; Su¨dhof, 2013) and its homologs VAMP1 and
VAMP3 that play a key role in synaptic vesicle fusion have
alanine in place of serine/threonine at the same internal positions
(Figs 2E and EV3A and B). This is significant since alanine resi-
dues cannot be phosphorylated and have a similar structural role
as non-phosphorylated serine/threonine. When examining 3,790
aligned eukaryotic VAMP protein sequences, particularly the resi-
dues 47 and 54 had a serine/threonine or alanine in 99.7 and
99.1% of the sequences, respectively (37.8% for position 53 and
91.3% for position 61) (Fig 2D and E). For every non-synaptic
VAMP4, VAMP5, VAMP7, VAMP8, SEC22B, YKT6, STXBP5,
STXBP6 homolog, between one and four of the internal residues
are serines or threonines whereas nearly every eukaryotic
VAMP1, VAMP2, and VAMP3 genes involved in synaptic vesicle
fusion (Su¨dhof, 2013) do not have residues that can be phospho-
rylated at the same sites (Figs 2E and EV3A and B). Thus, exclu-
sively the large group of non-synaptic VAMPs that mediate
slower secretion responses have evolutionary conserved internal
sites that allow for regulation by protein kinases. A similar regu-
lation may also occur in other SNARE proteins, since conserved
serine and threonine residues can be found at similar locations
within the SNARE domain of several other SNARE proteins
(Fig EV4A–C).
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Figure 1. Systematic identification of secretion-related phosphorylation targets of PKCB.
A IgE-induced b-hexosaminidase release. Maximal antigen stimulation releases only part of the vesicle pool and is inhibited dose dependently by PKCB inhibitor,
ruboxistaurin (n = 9). Values are mean  SEM.
B PKCB knockout in RBL-2H3 cells, achieved with genome editing using TALENs. Western blot validating complete loss of PKCB protein expression.
C IgE-induced b-hexosaminidase release was inhibited in PKCB knockout cells and was rescued with stable overexpression of either PKCB1 or PKCB2 (n = 24). Wild-type
RBL cells in pink and PKCB knockout cells in blue. Values are mean  SEM; ***P < 0.001, Kruskal-Wallis test with Dunn’s multiple comparisons test.
D Phosphoproteomics analysis of PKCB targets during mast cell secretion. Intensity for each phosphopeptide compared between biological replicas of wild-type cells
challenged with antigen.
E Schematic of how candidate phosphorylation sites were narrowed down to 179 secretion-connected phosphopeptides.
F Mean intensity for each phosphopeptide with WT compared to PKCB inhibitor versus WT compared to PKCB knockout cells. Dashed line represents threshold for
twofold change of intensity. The hits (179 phosphopeptides) are highlighted in blue and the 4 phosphopeptides from VAMP8 are highlighted in red: T53 (above both
thresholds), T47 (above one threshold), S54 (below both thresholds), and S17 (below both thresholds and site not perfectly conserved in mammals).
G VAMP8 immunocytochemistry imaged with a spinning disk confocal microscope. VAMP8 localized to vesicles in resting cells and expression was reduced after VAMP8
siRNA knockdown. VAMP8 translocated to the plasma membrane following antigen stimulation (4 min) (n = 3, > 50 cells per condition). Scale bar, 10 lm.
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Phosphomimetic VAMP8 reduces in vitro vesicle fusion
We hypothesized that phosphorylation of one or more of these
VAMP8 sites prior to the formation of the SNARE complex may
reduce SNARE-mediated fusion by steric hindrance and by the
added negative internal charge of the phosphate groups.
Incomplete zippering of the SNARE complex toward the C-term-
inal end may result in docked vesicles that fail to fuse with the
plasma membrane (Hernandez et al, 2012). To test the fusogenic
activity of VAMP8, we used in vitro ensemble content- and lipid-
mixing assays with SNARE proteins reconstituted in proteolipo-
somes (Materials and Methods) (Diao et al, 2015). We mixed
EA
B
C
D
Figure 2. Non-synaptic VAMPs have evolutionarily conserved phosphorylation sites located deep inside the SNARE complex.
A Crystal structure of VAMP8 in an autophagy SNARE complex (PDB: 4WY4). Residues T47, T53, S54, and S61 are shown as sticks-and-balls in the middle of the SNARE
complex in an orthogonal view.
B Accessible surface area for each residue in the VAMP8 SNARE domain (calculated from PDB: 4WY4). The 16 SNARE layers are all buried inside the SNARE complex
with minimal surface accessibility. The four phosphorylation sites (T47, T53, S54, and S61) all have low accessible surface areas.
C Sequence of rat VAMP8 SNARE domain compared to VAMP7 and VAMP2 (synaptobrevin). The 16 layers in the SNARE domain are highlighted in yellow and numbered
below, with arginine (R) at layer zero.
D Sequence logo for the 16 layers of the v-SNAREs examined (VAMP1, VAMP2, VAMP3, VAMP4, VAMP5, VAMP7, VAMP8, SEC22B, STXBP5, STXBP6, and YKT6) of 3,790
eukaryotic sequences. Serine or threonine residues are shown in red, alanine in blue, and all other in gray.
E An evolutionary comparison of 3,790 eukaryotic sequences of v-SNAREs, comparing the four phosphorylation sites (T47, T53, S54, and S61). Serine or threonine
residues are shown in red, alanine in blue, and any other amino acid in gray. Classification of species to the right.
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liposomes containing purified VAMP8 together with liposomes
containing both purified SNAP23 and STX3 (Figs 3A and EV5A)
(Sakiyama et al, 2009; Brochetta et al, 2014). As expected for
SNARE-mediated membrane fusion, wild-type non-phosphorylated
VAMP8 mediated content-mixing (Fig 3A and B) and lipid-mixing
(Fig EV5B). However, when combining SNAP23 and STX3
vesicles with vesicles that contain a phosphomimetic version of
VAMP8, VAMP8Glu (T47E, T53E, S54E), both the kinetics of
content-mixing (Fig 3B) and lipid-mixing (Fig EV5B) were
reduced, indicating that the kinetics of fusion is reduced by phos-
phorylation of these VAMP8 sites. Surprisingly, the effect of the
phosphomimetic mutations is not as severe as deletion mutants
in the C-terminal end of the neuronal SNARE complex that have
been studied previously (Hernandez et al, 2012). In accordance
with the reduced fusion kinetics, SDS-resistant SNARE complexes
were formed when combining SNAP23, STX3, and VAMP8
(Fig EV5C) and VAMP8Glu was less efficient in forming SNARE
complexes when compared to VAMP8 and VAMP8Ala (T47A,
T53A, S54A).
Phosphorylation of VAMP8 suppresses mast cell secretion
To directly test whether phosphorylation of VAMP8 suppresses
fusion in living cells, we measured secretion following antigen
stimulation in RBL cells expressing VAMP8 mutants in combination
with siRNA knockdown of endogenous VAMP8. We first confirmed
the role of VAMP8 in secretion by showing that knockdown of
VAMP8 reduced secretion, similar to previous mast cell studies
(Lippert et al, 2007; Puri & Roche, 2008; Tiwari et al, 2008), and
that this effect could be rescued with wild-type VAMP8 (Figs 4A
and EV5D and E). Of note, the sequence homolog VAMP3, VAMP4,
and VAMP7 did not rescue the secretion defect in cells with siRNA
knockdown of endogenous VAMP8 (Fig EV5F). To explore the role
of the conserved phosphorylation sites of VAMP8, we mutated
three sites (T47, T53, and S54) to alanine (VAMP8Ala), thus
preventing all three sites from being phosphorylated. If
phosphorylation of these sites had no functional relevance, secre-
tion would be unaffected as compared to wild-type VAMP8.
Instead, we observed that VAMP8Ala did not only rescue the
knockdown effect of VAMP8 siRNA, but was now able to trigger
secretion of a larger fraction of the total internal vesicle pool
compared to wild-type VAMP8 (Fig 4A). Furthermore, consistent
with the results of the in vitro fusion assays, the phosphomimetic
VAMP8Glu (T47E, T53E, S54E) failed to rescue the VAMP8 siRNA
suppression (Fig 4A). This argues that the normal antigen stimula-
tion response includes a PKCB-mediated suppression of secretion
and that VAMP8 phosphorylation constitutes a negative arm in the
incoherent feed-forward regulation of secretion.
To investigate which of the phosphorylation sites is most
relevant, we mutated each of the three sites individually to
glutamic acid (T47E, T53E, S54E) and the additional putative
phosphorylation site (S61E) which was found to be evolutionar-
ily conserved (Fig 2E). Markedly, all of the single-site mutants
failed to rescue mast cell secretion in the VAMP8 siRNA-treated
cells (Fig 4B). This suggests that phosphorylation on either
T47, T53, S54, or S61 alone is sufficient to completely abolish
VAMP8 function in the SNARE complex during mast cell
secretion.
Phosphorylation of VAMP8 prevents vesicle fusion but
not docking
Finally, to examine docking and fusion of VAMP8-containing vesicles
during secretion, we employed total internal reflection fluorescence
(TIRF) microscopy to image VAMP8 near the plasma membrane.
Fixing cells 4 min after antigen stimulation enabled us to distinguish
between fused vesicles, which result in VAMP8 uniformly diffusing
within the plasma membrane, and docked VAMP8 vesicles, which
are visible in TIRF as VAMP8 puncta. Interestingly, compared
to VAMP8Ala and VAMP8 expressing cells, VAMP8Glu had a
several-fold higher puncta density (Fig 4C–E), suggesting that
phosphorylation of VAMP8 still permits docking but prevents fusion
of vesicles with the plasma membrane (Fig 4F and G).
Discussion
Together, our proteomics analysis identifies several putative
substrates of PKCB such as MUNC18 (Brochetta et al, 2014; Genc
et al, 2014), SNAP23 (Polga´r et al, 2003; Lorentz et al, 2012),
STIM1 (Pozo-Guisado et al, 2010), and MYH9 (Ludowyke et al,
2006) (Appendix Table S1) that may enhance mast cell secretion
as a positive arm in the incoherent feed-forward regulation
(Fig 4F). Surprisingly, we also discovered that VAMP8 has an
evolutionarily conserved phosphorylation motif in the center of the
SNARE fusion complex that acts in parallel as a negative regula-
tory arm in the same circuit to prevent fusion (Fig 4G). Phospho-
rylation of VAMP8 at these internal residues can ensure that the
secretion response to even strong PKC stimuli is terminated and
that only a fraction of the stored vesicles is released. In the case of
mast cells, this is important as secretion needs to be tightly regu-
lated to prevent overreach such as anaphylactic shock (Kalesnikoff
& Galli, 2008). Based on our evolutionary analysis, the universal
conservation of internal serine and threonine residues inside
A B
Figure 3. Phosphomimetic VAMP8 reduces in vitro ensemble vesicle
fusion.
A Schematic of the in vitro ensemble content-mixing assay. v-SNARE vesicles
(VAMP8) loaded with content dye and unlabeled t-SNARE vesicles (SNAP23
and STX3).
B Reduced kinetics of content-mixing was observed with VAMP8Glu (T47E,
T53E, S54E) compared to wild-type VAMP8 (n = 3). As a control (black line),
the content-mixing assay was performed by combining v-SNARE vesicles
(VAMP8) loaded with dye with unlabeled t-SNARE vesicles prepared
without SNAP23 and STX3. The slight steady increase of the control is due
to a small amount of content dye leakage and consequent dequenching of
the dyes.
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Figure 4. Phosphorylation of VAMP8 suppresses fusion but not docking in mast cell secretion.
A IgE-induced b-hexosaminidase release in cells with siRNA knockdown of endogenous VAMP8. Wild-type RBL cells in white, VAMP8 in black, VAMP8Ala (T47A, T53A,
S54A) in blue, and VAMP8Glu (T47E, T53E, S54E) in red. VAMP8 siRNA reduced secretion, which was rescued by overexpressing VAMP8. VAMP8Ala further enhanced
secretion, whereas VAMPGlu failed to rescue the siRNA effect (n = 12). Values are mean  SEM; ***P < 0.001, one-way ANOVA with Bonferroni’s post hoc test.
B Single-site phosphomimetic mutant of VAMP8 failed to rescue the VAMP8 siRNA effect (n = 11). Values are mean  SEM.
C Immunocytochemistry of VAMP8 imaged at the plasma membrane using TIRF microscopy, following 4 min of antigen stimulation. Endogenous VAMP8 was knocked
down with siRNA. Expressed wild-type VAMP8 and VAMP8Ala (T47A, T53A, S54A) quickly assumed a uniform plasma membrane stain (due to VAMP8 vesicles fusion),
whereas VAMP8Glu (T47E, T53E, S54E) showed a punctate stain, representing vesicles docked at the plasma membrane without fusion. Scale bar, 10 lm.
D Identification of puncta in TIRF immunocytochemistry images using MATLAB (see Materials and Methods). Identified puncta are shown in white in the middle image.
Scale bar, 10 lm.
E Quantification of relative puncta density in TIRF immunocytochemistry images (n = 15, in total > 400 cells per condition). Values are mean  SEM; ***P < 0.001,
one-way ANOVA with Bonferroni’s post hoc test.
F PKCB forms an incoherent feed-forward loop with two parallel pathways, one suppressing fusion through VAMP8 phosphorylation and one promoting docking
through putative phosphorylation substrates.
G Vesicle fusion is suppressed by VAMP8 phosphorylation.
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SNARE complexes suggests that suppression by VAMP phosphoryla-
tion is a general mechanism by which cells can reduce non-synaptic
vesicle fusion and thereby prevent the complete release of all secre-
tory vesicles. We further speculate that suppression of membrane
fusion by phosphorylation constitutes a general mechanism for
SNARE proteins, since our analysis also revealed a similar phospho-
rylation motif in highly conserved residues in the SNARE domain of
SNARE-Qa, SNARE-Qb, and SNARE-Qc proteins (Fig EV4A–C).
Our data show that phosphomimetic VAMP8 decreases the kinet-
ics of SNARE-mediated fusion in vitro and, additionally, fail to
rescue the effect of VAMP8 siRNA on secretion in living cells.
Furthermore, alanine-substituted VAMP8 increases RBL cell secre-
tion, suggesting that VAMP8 phosphorylation inhibits mast cell
secretion. Key roles of this negative regulatory arm are likely to
provide a direct last minute break mechanism for fusion and also to
ensure that cells can trigger partial pulsed fusion responses that
leave the system capable to respond to future signal inputs. We
propose that there is a competition between VAMP8 phosphoryla-
tion and SNARE-mediated fusion, where protein kinase activity
decreases and phosphatase activity increases the probability of
VAMP8-mediated vesicle fusion events. This protein kinase-
controlled mechanism to abort secretion provides for a potential new
class of therapeutic strategies to inhibit the formation of specific
non-synaptic SNARE complexes to selectively suppress secretion asso-
ciated with inflammation, hormone release, or cancer progression.
Materials and Methods
Antibodies
VAMP8 (Synaptic Systems #104303), PKCB for Western blotting
(Santa Cruz Biotechnology #SC13149), PKCB for immunocyto-
chemistry (Santa Cruz Biotechnology #SC210), and mouse anti-DNP
IgE (Sigma-Aldrich #D8406).
Cell culture and secretion assay
The rat mast cell line RBL-2H3 was maintained in DMEM contain-
ing 10% FBS. For antigen-triggered secretion, cells were sensitized
by overnight incubation with 0.5 lg/ml monoclonal mouse anti-
DNP IgE (Sigma-Aldrich #D8406) and secretion was stimulated
with antigen (1 lg/ml DNP). Antigen was used to stimulate secre-
tion, except in Fig EV1A where 100 nM ionomycin (EMD Bios-
ciences #407952) together with 100 nM PDBu (Sigma-Aldrich
#P1269) was used to stimulate secretion. Cells were stimulated in
extracellular buffer (125 mM NaCl, 5 mM KCl, 20 mM HEPES,
1.5 mM MgCl2, 1.5 mM CaCl2, 10 mM D-glucose, pH 7.4). Secre-
tion was assessed by measuring release of b-hexosaminidase with
1.5 mM 4-methylumbelliferyl N-acetyl-b-D-glucosaminide (Sigma-
Aldrich #69585) in a fluorescent plate reader, Victor3 (Perkin-
Elmer), at 37°C with RBL cells cultured in plastic 96-well plates.
b-hexosaminidase levels were calculated by fitting a straight line to
11 measurement points acquired during 15 min. Cells were perme-
abilized with 0.5% Triton X-100 to quantify b-hexosaminidase
retained in cells. Mean and standard error of the mean were calcu-
lated from multiple wells. In VAMP8 siRNA knockdown experi-
ments, when comparing levels of secretion between stable cell
lines expressing different VAMP8 mutants, secretion was normal-
ized to siCtrl in the same stable cell line.
siRNA knockdown and DNA constructs
For siRNA knockdown, cells were electroporated using a
custom-built gold-plated 96-well electroporator (siRNAs at 1 lM
and 13,500 cells per well) as described previously (Guignet & Meyer,
2008) and cultured for 48–72 h. Pools of four targeting siRNAs were
purchased as SMARTpool siGENOME from Dharmacon. siRNA
knockdown of VAMP8 was verified with qPCR using TaqMan Gene
Expression Cells-to-CT Kit (Applied Biosystems #4399002 and
#Rn00582868_m1) according to manufacturer’s instructions. Lenti-
virus-mediated transduction was used for stable overexpression.
PKCB1 and PKCB2 were PCR-amplified from a RBL-2H3-derived
cDNA library and TOPO-cloned into pENTR/D-TOPO. Gateway LR
clonase was subsequently used for transfer into a custom-made
lentiviral Gateway destination vector (pLV-EF1a-mCitrine-N-DEST)
to yield PKCB1-mCitrine and PKCB2-mCitrine. cDNA sequences
encoding wild-type and mutant versions of VAMP8 were designed
to have flanking 25-bp homologies with a lentiviral vector and
purchased from Integrated DNA Technologies. All VAMP8
sequences were siRNA resistant due to silent mutations and
expressed without fluorescent tags. Untagged VAMP8 was used
since fluorescently tagged VAMP8 had expected cellular localiza-
tion, but failed to rescue the inhibitory effect of siVAMP8 on secre-
tion. VAMP8 wild-type, VAMP8Ala (T47A, T53A, S54A),
VAMP8Glu (T47E, T53E, S54E), and single amino acid substitutions
(VAMP8T47E, VAMP8T53E, VAMP8S54E, VAMP8S61E) were used.
VAMP8 sequences were ligated into a custom-made lentiviral vector
(pLV-EF1a-MCS-IRES-mCitrine) by Gibson assembly (Gibson et al,
2009). Transduced cells expressed untagged VAMP8 variants along
with IRES-driven cytoplasmic mCitrine enabling their isolation by
FACS. The sequence for siRNA-resistant wild-type VAMP8 with amino
acids sequence matching rat is as follows: ATGGAAGCTTCCGGCTC
CGCTGGCAACGATAGGGTGCGCAATCTCCAATCCGAAGTCGAAGG
CGTGAAAAACATCATGACTCAAAACGTCGAAAGAATTCTCGCTCG
CGGCGAAAATCTCGATCACTTGCGCAATAAAACCGAAGATCTCGA
GGCTACCAGCGAGCATTTTAAAACCACCAGTCAAAAAGTCGCTAG
AAAATTTTGGTGGAAAAACGTCAAAATGATCGTGATTATTTGCGTC
ATCGTGTTGATTATCTTGATTCTGATTATTTTGTTCGCCACCGGGAC
TATTCCTACCTGA. Lentiviral particles were generated in HEK-293
cells by cotransfecting a transfer vector and the packaging plasmids
pMDLG/pRRE, pRSV-rev, and pCMV-VSVG. Supernatants contain-
ing virus were collected 48 and 72 h post-transfection, sterile-
filtered using 0.22-lm Steriflip filtration units, and concentrated
using Amicon Ultra Centrifugal filters (100K cutoff). RBL-2H3 cells
were infected and transduced cells were selected with FACS. DNA
plasmids for VAMP3, VAMP4, and VAMP7 were prepared as
described for VAMP8 and matched the amino acid sequence for rat.
DNA plasmids used for SNARE reconstitution were human full-
length VAMP8, STX3, and SNAP23. The previously described
VAMP8 (Diao et al, 2015) plasmid was mutated using QuickChange
site-directed mutagenesis kit (Stratagene) to create VAMP8Glu
(T48E, T54E, S55E, these are the human amino acids that corre-
spond to rat amino acids T47E, T53E, S54E). Full-length human
STX3 fused with a N-terminal, TEV protease-cleavable, hexa-
histidine tag in expression vector pJ414 was synthesized (DNA2.0).
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Full-length human SNAP23 was a kind gift from Dr. Yeon-Kyun Shin
at Iowa State University. All cysteines in SNAP23 were mutated to
serine, using QuickChange site-directed mutagenesis kit (Strata-
gene), to facilitate reconstitution.
Genome editing
Transcription activator-like effector nucleases (TALENs) targeting
the first exon of PKCB were assembled following the Golden Gate
cloning strategy (Cermak et al, 2011) and transiently expressed,
together with an empty mCitrine plasmid, in RBL-2H3 cells using a
custom-built gold-plated electroporator (Guignet & Meyer, 2008).
Following 48 h of culture, cells were sorted by FACS to enrich the
expression of TALENs, then cultured for a week and subsequently
subjected to single-cell sorting into a 96-well plate. The single-cell
clones were expanded, and aliquots were fixed, and immunostained
for PKCB. Clones with low anti-PKCB signal were selected and the
genomic DNA of PKCB was sequenced. A cell clone with deletions
in the region of PKCB targeted by the TALENs was identified and
the complete knockout was verified by Western blotting.
Proteomics: cell stimulation
RBL-2H3 cells were incubated overnight with anti-DNP IgE (0.5 lg/ml),
washed with extracellular buffer, and stimulated with antigen
(1 lg/ml DNP) for 2 min at 37°C. Cells were then washed in cold
PBS, harvested, and snap-frozen in liquid N2. Three different condi-
tions of stimulation were used: WT cells, PKCB knockout cells,
and WT cells treated with 10 lM ruboxistaurin (Sigma-Aldrich
#SML0693). Three biological replicas were performed on three
different days with six 15-cm dishes for each condition (54 dishes in
total for all replicas and all conditions).
Proteomics: protein extraction, reduction, alkylation,
and digestion
Cell samples were lysed using a lysis buffer (8 M urea in 50 mM
NH4HCO3, containing complete mini EDTA-free cocktail and phos-
phoSTOP phosphatase inhibitor cocktail), followed by a sonication
step for 1 min at 50% cycle in ice to maximize protein extraction.
The extracted protein amount was first quantified by a Bradford
protein assay; afterward, protein samples were reduced with 2 mM
dithiothreitol (DTT) for 60 min at 37°C and alkylated with 4 mM
iodoacetamide for 30 min at RT in the dark. DTT was further added
to a final concentration of 4 mM to reduce overalkylation and
samples further incubated for 30 min at room temperature. After-
ward, samples were predigested with a Lys-C endopeptidase at an
enzyme/substrate ratio 1:100 (w/w) by incubating at 37°C for 3 h.
Samples were then diluted with 50 mM NH4HCO3 to a final concen-
tration of urea below 2 M (pH 7.5) and trypsin (Promega, Madison,
WI, USA) was added to a final enzyme/substrate ratio of 1:100
(w/w). Tryptic digestion was conducted overnight at 37°C. The
digestion was quenched by acidification with formic acid (FA) to a
final pH < 3. Peptide samples were desalted by solid-phase extrac-
tion. Briefly, samples were loaded onto Sep-Pak tC18 cartridges
(Waters, Milford, MA, USA), desalted by 2 washing steps with water
containing 0.1% FA, and eluted with 80% acetonitrile (ACN)
containing 6% trifluoroacetic acid (TFA).
Proteomics: phosphopeptide enrichment with TiO2 beads
Peptide samples were subjected to a phosphopeptide enrichment
step employing TiO2 material (Titansphere, 5 lm, GL Sciences,
Japan), with high selectivity for phosphorylated compounds. The
TiO2 beads were weighed in an Eppendorf tube (1 mg of beads per
1 mg of protein digest) and activated with methanol, followed by
two conditioning steps with loading buffer (80% ACN, 6% TFA).
Peptide samples, already dissolved in the loading buffer, were
mixed with the beads and incubated for 1 h, while gently vortex-
ing, at room temperature. Afterward, three sequential washing
steps of the phosphopeptide-bound beads were performed with (i)
loading buffer; (ii) 50% ACN, 0.5% TFA, 200 mM NaCl; and (iii)
50% ACN, 0.1% TFA. The bound phosphopeptides were then
eluted with 5% ammonia solution (pH > 10). The collected eluate
was immediately acidified by adding 100% TFA (to a final pH <3)
to prevent hydrolysis of the phospho-groups. The resulting phos-
phopeptides were further desalted using C18 MicroSpin Column
(The Nest Group, MA), eluted with 80% ACN, 0.1% FA, dried in
vacuo, and stored at 80°C for subsequent mass spectrometry
analysis.
Proteomics: shotgun phospho-proteomics analysis
A Q Exactive Plus (Thermo Fisher Scientific) mass spectrometer,
equipped with an EASY nanoLC 1000 system (Thermo Fisher Scien-
tific), was employed for shotgun phospho-proteomics measurement.
Peptides were separated on a 40-cm-long 75-lm i.d. in-house
packed column (1.9 lm, ReproSil-Pur 120 C18-AQ, Dr. Maisch,
Germany) using a 100 min gradient from 5% ACN to 25% ACN.
The mass spectrometer was operated in data-dependent mode,
automatically switching between MS and MS/MS. In the Q Exactive,
full-scan MS spectra (from m/z 350 to 1,500) were acquired with a
resolution of 70,000 FHMW at 200 m/z after accumulation to target
value of 3e6 in the C-trap (maximum injection time was 64 ms).
After the survey scans, the twenty most intense precursor ions at an
intensity threshold above 3.6e4 were selected for MS/MS with an
isolation width of 1.4 Da after accumulation to a target value of 1e5
(maximum injection time was 55 ms). MS/MS scan resolution was
17,500 FHMW. Peptide fragmentation was carried out by higher-
energy collisional dissociation (HCD), with a normalized collision
energy (CE) of 25. MS raw data from the shotgun LC-MS/MS
analyses were processed by MaxQuant (1.4.1.2) searching against a
rat database (UniProt), with trypsin digestion allowing 2 missed
cleavages, carbamidomethylation (C) as fixed modification and
oxidation (M), and phosphorylation (STY) as variable modifications.
Main search precursor tolerance was set to 10 ppm and MS/MS to
20 ppm. For quantification, the label-free quantification module
was activated.
Proteomics: data analysis
Data were normalized between runs to have same median intensity.
Peptides with intensities close to the noise level were excluded
(log2(intensity) < 21). Average values, shown in Fig 1F and
Appendix Table S1, were calculated by taking the mean of the 2
highest values. In cases where only 2 measurements existed, those 2
were averaged, and if only one existed, that value was used.
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Microscopy
Endogenously expressed VAMP8 was knocked down with siRNA in
cells with stable overexpression of VAMP8, VAMP8Ala (T47A,
T53A, S54A), or VAMP8Glu (T47E, T53E, S54E). Secretion was
stimulated by antigen treatment for 4 min, and cells were then fixed
in 4% PFA, followed immunostaining with permeabilization/block-
ing solution (0.1% Triton X-100, 10% FBS, 1% BSA, 0.01% NaN3,
in PBS). A custom-built prism-based total internal reflection fluores-
cence (TIRF) microscope was used for fluorescent imaging at the
plasma membrane with a 594 nm laser, as previously described
(Wollman & Meyer, 2012). Vesicles (puncta) were quantified using
MATLAB (MathWorks). Briefly, images were background subtracted
and top-hat filtering was used to identify puncta. Puncta intensity
was calculated by taking the median of the VAMP8 immunofluores-
cence signal of each puncta. Relative puncta density was calculated
by normalizing number of puncta for each image to cell density, by
dividing with the sum of all pixels for the nuclear marker Hoechst
33342, and then normalizing the cell line expressing VAMP8 to 1.0.
Images shown in Fig 1G were captured using a custom assembled
Yokogawa spinning disk confocal system built around a Zeiss Axio-
vert 200M microscope with a confocal spinning disk head (Yoko-
gawa CSU22), a QuantEM:512SC EMCCD camera (Photometrics), a
514 nm laser (Ar-Kr, 400 mW, Melles Griot), a 63× 1.2 NA C-
Apochromat water immersion objective and controlled by lManager
(Edelstein et al, 2014). Ca2+ imaging (Fig EV1D and E) and screen-
ing for PKCB knockout clones (immunostaining with PKCB anti-
body) were done using a fully automated fluorescence microscope
(ImageXpress Micro XL, Molecular Devices), equipped with a Sola
Light Engine (Lumencor), a Zyla 5.5 sCMOS camera (Andor), and a
20× 0.75 NA Plan Apo objective (Nikon). Cells for Ca2+ imaging
were loaded with the Ca2+-sensitive fluorescent indicator Fluo-3/
AM (Invitrogen) at 5 lM for 30 min in full growth media at 37°C
and then imaged in extracellular buffer as described previously
(Malmersjo¨ et al, 2013).
Bioinformatics
To assess the conservation of phosphorylation sites among different
species, we used the standalone versions of CPhos (Zhao et al,
2012) (http://helixweb.nih.gov/CPhos) to calculate a score for each
identified phosphorylation site in our phosphoproteomics data. Only
phosphorylation sites with a perfect phosphorylation score (phos-
phorylation site score = 1) for mammals were considered. Using
Ingenuity Pathway Analysis (www.ingenuity.com), we searched for
genes important for degranulation (259 genes), exocytosis (385
genes), and secretion (730 genes), in total 1,013 unique genes. Out
of these 1,013 genes known to be involved in secretion, 545 genes
were present in our phosphoproteomics data set. Analysis of the
evolutionarily conserved phosphorylation sites in VAMP8 and other
v-SNAREs were performed with a custom script in MATLAB (Math-
Works). Briefly, homologs of the different rat v-SNAREs (R-SNARE,
NCBI cd15843: VAMP1, VAMP2, VAMP3, VAMP4, VAMP5, VAMP7,
VAMP8, SEC22B, STXBP5, STXBP6, and YKT6) were identified by
NCBI BLAST against all RefSeq for eukaryotes. The BLAST hits were
considered homologs if reverse BLAST against rat RefSeq database
mapped back to the initial blast query. The SNARE domain of the
homolog sequences was then aligned and serine, threonine, and
alanine residues were identified. A similar analysis was done for
SNARE-Qa, SNARE-Qb, and SNARE-Qc (NCBI cd15840, cd15841,
cd15842). Accessible surface area for each amino acid was calcu-
lated from the crystal structure of PDB: 4WY4 (Diao et al, 2015)
using STRIDE (http://webclu.bio.wzw.tum.de/stride) (Heinig &
Frishman, 2004). PyMol was used to visualize the crystal structure.
SNARE reconstitution and proteoliposome preparation for the
ensemble lipid-mixing assay
v-SNARE vesicles contained reconstituted VAMP8, while t-SNARE
vesicles contained reconstituted STX3 and SNAP23. For v-SNARE
vesicles, the lipid composition was phosphatidylcholine (PC)
(78%), phosphatidylserine (PS) (20%), and 1,10-dioctadecyl-
3,3,30,30-tetramethylindodicarbocyanine perchlorate (DiD) (2%),
and for t-SNARE vesicles, the lipid composition was phosphatidyl-
choline (PC) (78%), phosphatidylserine (PS) (20%), and 1,10-diocta-
decyl-3,3,30,30-tetramethylindocarbocyanine perchlorate (DiI) (2%)
(Molecular Probes). The lipid mixtures PS:PC:DiD or PS:PC:DiI were
solubilized in chloroform and then dried to form a lipid film on the
wall of a glass tube. The dried lipid film was resuspended in proteo-
liposome buffer (20 mM HEPES, 90 mM KCl, pH 7.4). After five
freeze–thaw cycles, unilamellar proteoliposomes were extruded
through polycarbonate filters (100 nm pore size, Avanti Polar
Lipids) at least 39 times. For reconstitution, t-SNAREs were pre-
assembled by mixing STX3 and SNAP23 at the ratio of 1:2 at room
temperature for 15 min. The proteins (STX3/SNAP23 or VAMP8)
and liposomes were mixed together at the desired lipid to protein
(L/P) ratio of 200~500. Then, the mixture containing ~0.8% octyl
glucoside (OG) in the buffer was kept at 4°C for 20 min. The
mixture was diluted two times with proteoliposome buffer and dial-
ysis in 2 l proteoliposome buffer overnight, causing insertion of
proteins into the vesicle membranes by detergent depletion.
SNARE reconstitution and proteoliposome preparation for the
ensemble content-mixing assay
The lipid composition for both v-SNARE and t-SNARE vesicles was
phosphatidylcholine (PC) (80%) and phosphatidylserine (PS)
(20%). The t-SNARE proteoliposomes were prepared by extrusion
as described above for the lipid-mixing assay. For preparation of the
v-SNARE vesicles, liposomes containing sulforhodamine B (Invitro-
gen) were initially also prepared by extrusion and then mixed with
VAMP8 (at a L/P ratio of 500:1) in proteoliposome buffer with a
final concentration of ~0.8% OG and 50 mM sulforhodamine B.
Then, this mixture was kept at 4°C for 20 min. Detergent-free prote-
oliposome buffer plus 50 mM sulforhodamine B was added to the
protein–lipid mixture until the detergent concentration was 0.4%
(which is slightly below the critical micelle concentration of
~0.7%), that is, vesicle partially form. The v-vesicles subsequently
reformed during size exclusion chromatography using a Sepharose
CL-4B column, packed under near constant pressure by gravity with
a peristaltic pump (GE Healthcare, Uppsala, Sweden) in a 5 ml
column with a 2 ml bed volume, that was equilibrated with buffer V
(20 mM HEPES, pH 7.4, 90 mM NaCl, 20 lM EGTA, and 0.1%
2-mercaptoethanol). The eluent was subjected to dialysis in 2 l prote-
oliposome buffer overnight. We note that for v-SNARE vesicles, the
chromatography equilibration and elution buffers did not contain
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sulforhodamine B, so the effective sulforhodamine B concentration
inside v-SNARE vesicles is considerably, up to tenfold, lower than
50 mM.
Ensemble lipid- and content-mixing assays
Protein-reconstituted v-SNARE and t-SNARE vesicles were mixed at
a molar ratio of 1:1, both at 0.1 mM lipid concentration. The ensem-
ble lipid-mixing experiments were carried out with DiI donor dye-
and DiD acceptor dye-labeled (proteo-) liposomes as described
previously (Su et al, 2008). Protein-reconstituted t-SNARE and
v-SNARE proteoliposomes were mixed at a molar ratio of 1:1. Lipid-
mixing is measured as the fluorescent emission (670 nm) of DiD
dyes in v-SNARE vesicles by FRET using 530 nm laser light excita-
tion of the DiI dyes in t-SNARE vesicles. The fluorescence intensity
was monitored in two channels at 570 and 670 nm, respectively.
For the ensemble content-mixing assay, self-quenched sulforho-
damine B molecules encapsulated in the v-SNARE vesicles were
used as a content indicator. Experiments were measured by an
increase of fluorescence emission at 570 nm of the sulforhodamine
B dyes upon 530 nm excitation that results as the initially self-
quenched dye is diluted upon complete fusion (i.e. content-mixing)
between labeled v-SNARE vesicles and unlabeled t-SNARE vesicles.
Fluorescence changes were recorded with a Varian Cary Eclipse
model fluorescence spectrophotometer using a quartz cell of 100 ll
with a 5 mm path length.
SNARE complex formation
SNARE complexes in Fig EV5C were formed by mixing purified
VAMP8 (alternatively VAMP8Glu or VAMP8Ala) together with STX3
and SNAP23 at a molar ratio of 1:1:1, in SDS sample buffer, at room
temperature for 30 min. Half of the samples were then boiled for
5 min. Proteins were separated using SDS–PAGE followed by
Coomassie Blue staining of the gel.
Full-length VAMP8, STX3, and SNAP23 expression and purification
Human full-length VAMP8, STX3, and SNAP23 were expressed and
purified according to previously reported protocols (Studier, 2005;
Diao et al, 2015) with modifications. Briefly, SNAP23 and VAMP8
were expressed as N-terminal GST fusions in BL21 (DE3) cells. The
fusion proteins were bound to glutathione Sepharose 4B (GE
Healthcare), washed, and eluted by cleaving the protein from the
GST using thrombin in the case of SNAP23 and TEV protease in the
case of VAMP8 and VAMP8Glu. n-octyl glucoside detergent was
used in the buffers for SNAP23 and VAMP8 to maintain the
solubility of proteins. STX3 was expressed as an N-terminal 6 His tag
fusion protein and purified on nickel NTA agarose (Qiagen) followed
by removal of the 6 His tag by TEV protease cleavage and further
purification on a MonoQ anion exchange column (GE Healthcare).
Statistical analysis
In all graphs, data are presented as mean values  SEM. Statistical
analysis was performed with MATLAB (MathWorks) or Prism
(GraphPad). Bartlett’s test was used to check equality of variance. In
the case of equal variances, Student’s t-test or one-way ANOVA with
Bonferroni’s post hoc test was used, with significance levels
*P < 0.05, **P < 0.01, or ***P < 0.001. In the case of unequal vari-
ances, data were log-transformed to achieve equal variances or the
nonparametric Mann–Whitney U- or Kruskal–Wallis tests were used.
Expanded View for this article is available online.
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